血管形成術用バルーン・ステント - 世界市場の考察、競合情勢、市場予測（2030年）

世界の血管形成術用バルーン・ステントの市場規模は、2024年～2030年の予測期間にCAGRで3.67%の成長が推定されます。血管形成術用バルーン・ステントの需要は主に、心血管疾患（CVD）患者の増加、低侵襲処置の需要の増加、薬剤コーティング/薬剤溶出性バルーンにおける技術革新の進行などによって押し上げられています。さらに、血管形成術用バルーン・ステント市場は、この分野で進行中の多数の研究活動、医療提供者、研究者、業界参入企業の提携、戦略的パートナーシップなどによる成長が予測され、これらが2024年～2030年の予測期間における市場全体の成長に寄与する見通しです。

血管形成術用バルーン・ステントの市場力学

American Heart Association（2022）のデータによると、2020年に世界で約2億4,410万人が冠動脈（虚血性）心疾患を患っています。

British Heart Foundation（2022）のデータによると、2019年に全世界で約5億5,000万人（14人に1人）が心臓および循環器の疾患とともに生活しており、これには約2億9,000万人の女性と約2億6,000万人の男性が含まれます。同じ資料によると、2019年、北米では410万3,135人がを心血管疾患に罹患し、108万9,947人が冠動脈疾患と診断され、49万8,551人が脳卒中に罹患し、アジアでは3,237万6,834人が心血管疾患と診断され、そのうち1,254万3,833人が冠動脈疾患に罹患し、811万1,044人が脳卒中に罹患しました。

上記の資料はさらに、冠動脈（虚血性）心疾患、末梢動脈（血管）疾患、脳卒中、心房細動が2019年においても世界でもっとも一般的で有病率の高い心血管疾患であったと述べています。

肥満、高血圧、糖尿病、喫煙、高齢、飲酒、不健康な生活習慣、アテローム性動脈硬化症などの、何らかの形で心血管疾患の発症を引き起こす危険因子の増加は、血管形成術用バルーン・ステント市場をさらに加速させる見通しです。

WHO（2022）が提供したデータによると、2020年に世界中で約10億人が60歳以上でした。2050年までに60歳以上の老年人口は倍増し、約21億人に達すると予測されています。

調査研究によると、PADの有病率は年齢とともに増加し、60歳未満の3%に発症しますが、その有病率は70歳超で15%～20%に増加します。

したがって、上記の要因により血管形成術用バルーン・ステント市場は予測期間に成長すると推定されます。

しかし、厳しい規制手続きによる悪影響や製品リコールが、血管形成術用バルーン・ステント市場全体の成長を抑制する可能性があります。

血管形成術用バルーン・ステント市場のセグメント分析

血管形成術用バルーン・ステント市場のバルーンカテゴリの製品タイプセグメントでは、薬剤コーティングバルーンが2023年に大きな収益シェアを獲得する見込みです。

冠動脈疾患と末梢動脈疾患の治療における薬剤コーティングバルーンの利点と用途が、その需要を増大させる見通しです。

薬剤コーティングバルーン（DCB）血管形成術は、処置的には従来のバルーン血管形成術（POAB）と同等ですが、バルーンに抗増殖薬と賦形剤がコーティングされており、薬物移送を促進します。

薬剤コーティングバルーンは再狭窄の予防に役立ちます。薬剤コーティングバルーンを使用することで、細胞分裂が阻害され、治療後の再狭窄、つまり閉塞の再生の程度が軽減される可能性があります。

DCB血管形成術の際に異物を植込まないことで、患者の身体は冠動脈の元の解剖学的構造の変化から免れるだけでなく、後期ステント血栓症やアレルギーのようなリスクからも免れます。

さらに、特に若い患者にとっては、さらなる手術による治療やインターベンション治療の可能性がもたらされます。

当レポートでは、世界の血管形成術用バルーン・ステント市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 血管形成術用バルーン・ステント市場レポートのイントロダクション

第2章 血管形成術用バルーン・ステント市場のエグゼクティブサマリー

• 調査範囲
• 市場の概要
• 競合の評価

第3章 規制分析

• 米国
• 欧州
• 日本
• 中国

第4章 血管形成術用バルーン・ステント市場の主な要因の分析

• 血管形成術用バルーン・ステント市場の促進要因
• 血管形成術用バルーン・ステント市場の抑制要因と課題
• 血管形成術用バルーン・ステント市場の機会

第5章 血管形成術用バルーン・ステント市場のポーターのファイブフォース分析

第6章 血管形成術用バルーン・ステントの市場レイアウト

• 製品タイプ
• バルーン
  • 薬剤コーティングバルーン
  • 従来式バルーン
• ステント
  • 薬剤溶出性ステント
  • ベアメタルステント
• 適応症別
  • 冠動脈疾患
  • 末梢動脈疾患
• エンドユーザー別
  • 病院
  • 外来手術センター
  • カテーテル検査室
• 地域
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第7章 血管形成術用バルーン・ステント市場の企業と製品のプロファイル

• B. Braun SE
• BIOTRONIK
• Medtronic
• Abbott
• Boston Scientific Corporation
• Cook
• Biosensors International Group, Ltd.
• MicroPort Scientific Corporation
• Terumo Corporation
• BD
• Demax Medical Technology
• BrosMed Medical Co., Ltd.
• Cordis
• Sino Medical Sciences Technology Inc.
• Concept Medical

第8章 KOLの見解

第9章 プロジェクトアプローチ

第10章 DelveInsightのサービス内容

第11章 DelveInsightについて

第12章 免責事項、お問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: Angioplasty Balloons and Stents Market in Global (2021-2030)
• Table 3: Angioplasty Balloons and Stents Market in Global by Product Type (2021-2030)
• Table 4: Angioplasty Balloons and Stents Market in Global by Indication (2021-2030)
• Table 5: Angioplasty Balloons and Stents Market in Global by End-User (2021-2030)
• Table 6: Angioplasty Balloons and Stents Market in Global by Geography (2021-2030)
• Table 7: Angioplasty Balloons and Stents Market in North America (2021-2030)
• Table 8: Angioplasty Balloons and Stents Market in the US (2021-2030)
• Table 9: Angioplasty Balloons and Stents Market in Canada (2021-2030)
• Table 10: Angioplasty Balloons and Stents Market in Mexico (2021-2030)
• Table 11: Angioplasty Balloons and Stents Market in Europe (2021-2030)
• Table 12: Angioplasty Balloons and Stents Market in France (2021-2030)
• Table 13: Angioplasty Balloons and Stents Market in Germany (2021-2030)
• Table 14: Angioplasty Balloons and Stents Market in the United Kingdom (2021-2030)
• Table 15: Angioplasty Balloons and Stents Market in Italy (2021-2030)
• Table 16: Angioplasty Balloons and Stents Market in Spain (2021-2030)
• Table 17: Angioplasty Balloons and Stents Market in the Rest of Europe (2021-2030)
• Table 18: Angioplasty Balloons and Stents Market in Asia-Pacific (2021-2030)
• Table 19: Angioplasty Balloons and Stents Market in China (2021-2030)
• Table 20: Angioplasty Balloons and Stents Market in Japan (2021-2030)
• Table 21: Angioplasty Balloons and Stents Market in India (2021-2030)
• Table 22: Angioplasty Balloons and Stents Market in Australia (2021-2030)
• Table 23: Angioplasty Balloons and Stents Market in South Korea (2021-2030)
• Table 24: Angioplasty Balloons and Stents Market in Rest of Asia-Pacific (2021-2030)
• Table 25: Angioplasty Balloons and Stents Market in the Rest of the World (2021-2030)
• Table 26: Angioplasty Balloons and Stents Market in the Middle East (2021-2030)
• Table 27: Angioplasty Balloons and Stents Market in Africa (2021-2030)
• Table 28: Angioplasty Balloons and Stents Market in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: Angioplasty Balloons and Stents Market in Global (2021-2030)
• Figure 3: Angioplasty Balloons and Stents Market in Global by Product Type (2021-2030)
• Figure 4: Angioplasty Balloons and Stents Market in Global by Indication (2021-2030)
• Figure 5: Angioplasty Balloons and Stents Market in Global by End-User (2021-2030)
• Figure 6: Angioplasty Balloons and Stents Market in Global by Geography (2021-2030)
• Figure 7: Angioplasty Balloons and Stents Market in North America (2021-2030)
• Figure 8: Angioplasty Balloons and Stents Market in the US (2021-2030)
• Figure 9: Angioplasty Balloons and Stents Market in Canada (2021-2030)
• Figure 10: Angioplasty Balloons and Stents Market in Mexico (2021-2030)
• Figure 11: Angioplasty Balloons and Stents Market in Europe (2021-2030)
• Figure 12: Angioplasty Balloons and Stents Market in France (2021-2030)
• Figure 13: Angioplasty Balloons and Stents Market in Germany (2021-2030)
• Figure 14: Angioplasty Balloons and Stents Market in the United Kingdom (2021-2030)
• Figure 15: Angioplasty Balloons and Stents Market in Italy (2021-2030)
• Figure 16: Angioplasty Balloons and Stents Market in Spain (2021-2030)
• Figure 17: Angioplasty Balloons and Stents Market in the Rest of Europe (2021-2030)
• Figure 18: Angioplasty Balloons and Stents Market in Asia-Pacific (2021-2030)
• Figure 19: Angioplasty Balloons and Stents Market in China (2021-2030)
• Figure 20: Angioplasty Balloons and Stents Market in Japan (2021-2030)
• Figure 21: Angioplasty Balloons and Stents Market in India (2021-2030)
• Figure 22: Angioplasty Balloons and Stents Market in Australia (2021-2030)
• Figure 23: Angioplasty Balloons and Stents Market in South Korea (2021-2030)
• Figure 24: Angioplasty Balloons and Stents Market in Rest of Asia-Pacific (2021-2030)
• Figure 25: Angioplasty Balloons and Stents Market in the Rest of the World (2021-2030)
• Figure 26: Angioplasty Balloons and Stents Market in the Middle East (2021-2030)
• Figure 27: Angioplasty Balloons and Stents Market in Africa (2021-2030)
• Figure 28: Angioplasty Balloons and Stents Market in South America (2021-2030)
• Figure 29: Market Drivers
• Figure 30: Market Barriers
• Figure 31: Marker Opportunities
• Figure 32: PORTER'S Five Force Analysis

The Angioplasty Balloons And Stents Market By Product Type (Balloons [Drug-Coated Balloons And Plain Old Balloons], Stents [Drug-Eluting Stents And Bare Metal Stents]), Indication (Coronary Artery Disease And Peripheral Artery Disease), End-User (Hospitals, Ambulatory Surgical Centers, And Cath Labs), and geography is expected to grow at a steady CAGR forecast till 2030 owing to increasing number of cases of urinary tract infections (UTI) and increasing research and development activities

The global angioplasty balloons and stents market is estimated to grow at a CAGR of 3.67% during the forecast period from 2024 to 2030. The demand for angioplasty balloons and stents is primarily being boosted by the increasing number of people with cardiovascular diseases (CVDs), the rise in demand for minimally invasive procedures, growing innovations in drug-coated/drug-eluting balloons, and others. Furthermore, the angioplasty balloons and stents market is anticipated to grow on account of a large number of ongoing research activities in this field, collaborations between healthcare providers, researchers, and industry players, and strategic partnerships among others are going to contribute to the overall growth of the angioplasty balloons and stents market during the forecast period from 2024-2030.

Angioplasty Balloons And Stents Market Dynamics:

According to American Heart Association 2022 data, globally about 244.1 million people were living with coronary (ischemic) heart disease in 2020.

As per the data provided by British Heart Foundation 2022, worldwide around 550 million which stands for 1 in 14 people were living with heart and circulatory diseases in 2019 and this includes about 290 million women and around 260 million men. As per the same source, in 2019, in North America, cardiovascular diseases affected 4,103,135 people, 1,089,947 people were diagnosed with coronary artery disease, and 498,551 suffered from stroke; In Asia, there were 32,376,834 people diagnosed with cardiovascular diseases, from which 12,543,833 individuals were affected by coronary artery disease, and 8,111,044 population was suffered from a stroke.

The source mentioned above further stated that coronary (ischemic) heart disease (200 million cases), peripheral arterial (vascular) disease (110 million cases), stroke (100 million cases), and atrial fibrillation (60 million cases) remained the commonest and prevalent cardiovascular conditions worldwide in 2019.

The increasing number of risk factors such as obesity, hypertension, diabetes, smoking, old age, alcohol consumption, unhealthy lifestyle, atherosclerosis, and others causing the development of cardiovascular diseases in one way or another are further going to accelerate the market for angioplasty balloons and stents.

According to the data provided by the WHO (2022), in 2020, about one billion people across the world were over the age of 60. The source mentioned above added by stating that by 2050, the elderly population aged 60 and above is expected to double in number representing about 2.1 billion people.

As per research studies, the prevalence of PAD increases with age; it occurs in 3% of people <60 years, but its prevalence increases to 15% to 20% among individuals >70 years.

Thus, owing to the above-mentioned factors, the angioplasty balloons and stents market is estimated to grow during the forecast period.

However, stringent regulatory procedures adverse effects, and product recalls may restrict the growth of the overall angioplasty balloons and stents market.

Angioplasty Balloons And Stents Market Segment Analysis:

Angioplasty Balloons and Stents Market By Product Type (Balloons [Drug-Coated Balloons and Plain Old Balloons], Stents [Drug-Eluting Stents and Bare Metal Stents]), Indication (Coronary Artery Disease and Peripheral Artery Disease), End-User (Hospitals, Ambulatory Surgical Centers, and Cath Labs), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment under the balloons category of the Angioplasty Balloons and Stents market, the drug-coated balloons, category is expected to amass a significant revenue share in the year 2023.

The advantages and applications associated with drug-coated balloons in the treatment of coronary artery disease and peripheral artery disease are going to increase their demand.

Procedure-wise, Drug-Coated Balloon (DCB) angioplasty is comparable to Plain Old Balloon Angioplasty (POAB), but it includes coating the balloon with an anti-proliferative medicine and an excipient to facilitate drug transfer.

Drug-coated balloons aid in the prevention of restenosis, which is the vessel's re-narrowing at a previously treated spot. Employing a balloon coated with medication may prevent cell division, thereby reducing the degree of restenosis, or blockage regrowth, following therapy.

By not implanting a foreign body during the DCB angioplasty, the patient's body is spared from modifications to the coronary artery's original anatomical structure as well as risks such as late stent thrombosis and allergy.

Additionally, it offers chances for further surgical treatment or interventional therapy, especially for young patients.

The interventional process is comparatively easy, requiring less time to complete and exposing patients and medical personnel to less radiation.

By uniformly distributing the medication to the blood vessel's inner wall, DCB can prevent the delayed endothelialization brought on by the unequal dispersion of stent metal rods.

By applying DCB, the duration of dual antiplatelet medication can be shortened, and the risk of bleeding and other problems can be decreased.

For certain kinds of lesions, such as narrow lesions, high bleeding risk lesions, patients with diabetes, etc., DCB may be a better option than stent insertion.

Thus, all the above-mentioned factors are likely to propel the market for drug-coated balloons in Angioplasty Balloons and Stents.

North America is expected to dominate the overall Angioplasty Balloons And Stents Market:

Among all the regions, North America is estimated to account for the largest share of the Angioplasty Balloons and Stents market in the year 2023. This domination is due to the increasing application of angioplasty balloons and stents in the treatment and management of peripheral and coronary artery disease which are on the rise in the region, increasing sedentary lifestyle, anxiety, and stress resulting in chronic diseases, such as diabetes and obesity, leading to an increase in the prevalence of multiple cardiovascular diseases, rising product launch and approvals, presence of favorable regulatory authority, among others will propel the market of angioplasty balloons and stents in the US.

For instance, as per the study conducted by the Centre for Disease Control and Prevention (CDC) in 2023, it was stated that in 2021, about 1 in 20 adults age 20 and older have coronary artery disease (CAD). Coronary heart disease is the most common type of heart disease in the US, killing 375,476 people in 2021. In 2021, about 2 in 10 deaths from CAD happened in adults less than 65 years old. Thus, the high burden of cardiovascular diseases in the region demands the availability of drug-eluting balloons.

The American Heart Association in the latest study estimated that over 500,000 percutaneous coronary intervention (PCI) procedures are carried out annually in the US. Percutaneous coronary intervention with a drug-coated balloon (DCB) is a novel treatment that seeks to acutely dilate coronary stenosis and deliver an anti-proliferative drug to the vessel wall. Thus, the number of PCI procedures in the region will increase the demand for drug-eluting balloons.

Further, the availability of various major manufacturers, the launch and approval of new and technologically advanced devices, and favorable reimbursement regulations are all important factors responsible for driving the demand for drug-eluting balloons in the region. For instance, in November 2022, Genesis MedTech Group announced that the Food and Drug Administration (FDA) has approved the Chocolate Touch(R) Drug-coated Balloon PTA Catheter, developed by TriReme Medical LLC, for the treatment of patients with peripheral artery disease in the superficial femoral artery and the popliteal artery.

Thus, the above-mentioned factors are likely to propel the growth of the angioplasty balloons and stents market in the region during the forecast period from 2024-2030.

Angioplasty Balloons And Stents Market Key Players:

Some of the key market players operating in the Angioplasty Balloons and Stents market include B. Braun SE, BIOTRONIK, Medtronic, Abbott, Boston Scientific Corporation, Cook, Biosensors International Group, Ltd., MicroPort Scientific Corporation, Terumo Corporation, Demax Medical Technology, BD, BrosMed Medical Co., Ltd., Cordis, Sino Medical Sciences Technology Inc., Concept Medical, and Others.

Recent Developmental Activities in the Angioplasty Balloons And Stents Market:

• In January 2023, The US Food and Drug Administration (FDA) approved the Stellarex 0.035" OTW Drug-coated Angioplasty Balloon - P160049/S015, from Philips Image Guided Therapy Corp.
• In August 2019, B. Braun Interventional Systems Inc. (BIS) announced that the US Food and Drug Administration (FDA) granted Breakthrough Device Designation for the SeQuent Please ReX drug-coated PTCA balloon catheter.

Key Takeaways from the Angioplasty Balloons And Stents Market Report Study

• Market size analysis for current angioplasty balloons and stents market size (2023), and market forecast for 6 years (2024-2030)
• Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
• Key companies dominating the global Angioplasty Balloons and Stents market.
• Various opportunities available for the other competitors in the Angioplasty Balloons and Stents market space.
• What are the top-performing segments in 2023? How these segments will perform in 2030?
• Which are the top-performing regions and countries in the current Angioplasty Balloons and Stents market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for Angioplasty Balloons and Stents market growth in the coming future?

Target Audience who can be benefited from this Angioplasty Balloons And Stents Market Report Study

• Angioplasty Balloons and stent product providers
• Research organizations and consulting companies
• Angioplasty Balloons and Stents-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in Angioplasty Balloons and Stents
• Various End-users who want to know more about the Angioplasty Balloons and Stents market and the latest developments in the Angioplasty Balloons and Stents market.

Frequently Asked Questions for the Angioplasty Balloons And Stents Market:

1. What are angioplasty balloons and stents?

Angioplasty Balloons and Stents are intended for the effective treatment of coronary and peripheral artery disease by opening a narrowed or blocked artery.

2. What is the market for global Angioplasty Balloons and Stents?

The global angioplasty balloons and stents market is estimated to grow at a CAGR of 3.67% during the forecast period from 2024 to 2030.

3. What are the drivers for the global angioplasty balloons and stents market?

The demand for angioplasty balloons and stents is primarily being boosted by the increasing number of people with cardiovascular diseases (CVDs), the rise in demand for minimally invasive procedures, growing innovations in drug-coated/drug-eluting balloons, and others. Furthermore, the angioplasty balloons and stents market is anticipated to grow on account of a large number of ongoing research activities in this field, collaborations between healthcare providers, researchers, and industry players, and strategic partnerships among others are going to contribute to the overall growth of the angioplasty balloons and stents market during the forecast period from 2024-2030.

4. Who are the key players operating in the global angioplasty balloons and stents market?

Some of the key market players operating in the angioplasty balloons and stents market include B. Braun SE, BIOTRONIK, Medtronic, Abbott, Boston Scientific Corporation, Cook, Biosensors International Group, Ltd., MicroPort Scientific Corporation, Terumo Corporation, Demax Medical Technology, BD, BrosMed Medical Co., Ltd., Cordis, Sino Medical Sciences Technology Inc., Concept Medical, and Others.

5. Which region has the highest share in the angioplasty balloons and stents market?

North America is expected to dominate the overall Angioplasty Balloons and Stents market during the forecast period from 2024-2030. Owing to the significance of key growth factors such as the increasing patient pool with peripheral and coronary artery disease, increasing sedentary lifestyle, anxiety, and stress resulting in chronic diseases, such as diabetes and obesity, leading to an increase in the prevalence of multiple cardiovascular diseases. Further, rising product launches and approvals and, the presence of favorable regulatory authority, among others will propel the market of angioplasty balloons and stents in the US.

Table of Contents

1. Angioplasty Balloons and Stents Market Report Introduction

2. Angioplasty Balloons and Stents Market Executive Summary

• 2.1. Scope of the Study
• 2.2. Market at Glance
• 2.3. Competitive Assessment

3. Regulatory Analysis

• 3.1. The United States
• 3.2. Europe
• 3.3. Japan
• 3.4. China

4. Angioplasty Balloons and Stents Market Key Factors Analysis

• 4.1. Angioplasty Balloons and Stents Market Drivers
  • 4.1.1. The rising burden of cardiovascular diseases (CVDs) and its risk factors
  • 4.1.2. Growing technological advancement in the product portfolio
  • 4.1.3. Growing preference for minimally invasive procedures
• 4.2. Angioplasty Balloons and Stents Market Restraints and Challenges
  • 4.2.1. Inherent complications with angioplasty procedures
  • 4.2.2. Compliance and regulatory pressures
• 4.3. Angioplasty Balloons and Stents Market Opportunities
  • 4.3.1. Medical device expansion in developing regions coupled with government initiatives
  • 4.3.2. Increasing research and development activities w.r.t. angioplasty balloons and stents

5. Angioplasty Balloons and Stents Market Porter's Five Forces Analysis

• 5.1. Bargaining Power of Suppliers
• 5.2. Bargaining Power of Consumers
• 5.3. Threat of New Entrants
• 5.4. Threat of Substitutes
• 5.5. Competitive Rivalry

6. Angioplasty Balloons and Stents Market Layout

• 6.1. By Product Type
• 6.2. Balloons
  • 6.2.1. Drug-Coated Balloons
  • 6.2.2. Plain Old Balloons
• 6.3. Stents
  • 6.3.1. Drug-eluting Stents
  • 6.3.2. Bare Metal Stents
• 6.4. By Indication
  • 6.4.1. Coronary Artery Disease
  • 6.4.2. Peripheral Artery Disease
• 6.5. By End-User
  • 6.5.1. Hospitals
  • 6.5.2. Ambulatory Surgical Centers
  • 6.5.3. Cath Labs
• 6.6. By Geography
  • 6.6.1. North America
    • 6.6.1.1. United States Angioplasty Balloons and Stents Market Size in USD million (2021-2030)
    • 6.6.1.2. Canada Angioplasty Balloons and Stents Market Size in USD million (2021-2030)
    • 6.6.1.3. Mexico Angioplasty Balloons and Stents Market Size in USD million (2021-2030)
  • 6.6.2. Europe
    • 6.6.2.1. France Angioplasty Balloons and Stents Market Size in USD million (2021-2030)
    • 6.6.2.2. Germany Angioplasty Balloons and Stents Market Size in USD million (2021-2030)
    • 6.6.2.3. United Kingdom Angioplasty Balloons and Stents Market Size in USD million (2021-2030)
    • 6.6.2.4. Italy Angioplasty Balloons and Stents Market Size in USD million (2021-2030)
    • 6.6.2.5. Spain Angioplasty Balloons and Stents Market Size in USD million (2021-2030)
    • 6.6.2.6. Rest of Europe Angioplasty Balloons and Stents Market Size in USD million (2021-2030)
  • 6.6.3. Asia-Pacific
    • 6.6.3.1. China Angioplasty Balloons and Stents Market Size in USD million (2021-2030)
    • 6.6.3.2. Japan Angioplasty Balloons and Stents Market Size in USD million (2021-2030)
    • 6.6.3.3. India Angioplasty Balloons and Stents Market Size in USD million (2021-2030)
    • 6.6.3.4. Australia Angioplasty Balloons and Stents Market Size in USD million (2021-2030)
    • 6.6.3.5. South Korea Angioplasty Balloons and Stents Market Size in USD million (2021-2030)
    • 6.6.3.6. Rest of Asia-Pacific Angioplasty Balloons and Stents Market Size in USD million (2021-2030)
  • 6.6.4. Rest of the World (RoW)
    • 6.6.4.1. Middle East Angioplasty Balloons and Stents Market Size in USD million (2021-2030)
    • 6.6.4.2. Africa Angioplasty Balloons and Stents Market Size in USD million (2021-2030)
    • 6.6.4.3. South America Angioplasty Balloons and Stents Market Size in USD million (2021-2030)

7. Angioplasty Balloons and Stents Market Company and Product Profiles

• 7.1. B. Braun SE
  • 7.1.1. Company Overview
  • 7.1.2. Company Snapshot
  • 7.1.3. Financial Overview
  • 7.1.4. Product Listing
  • 7.1.5. Entropy
• 7.2. BIOTRONIK
  • 7.2.1. Company Overview
  • 7.2.2. Company Snapshot
  • 7.2.3. Financial Overview
  • 7.2.4. Product Listing
  • 7.2.5. Entropy
• 7.3. Medtronic
  • 7.3.1. Company Overview
  • 7.3.2. Company Snapshot
  • 7.3.3. Financial Overview
  • 7.3.4. Product Listing
  • 7.3.5. Entropy
• 7.4. Abbott
  • 7.4.1. Company Overview
  • 7.4.2. Company Snapshot
  • 7.4.3. Financial Overview
  • 7.4.4. Product Listing
  • 7.4.5. Entropy
• 7.5. Boston Scientific Corporation
  • 7.5.1. Company Overview
  • 7.5.2. Company Snapshot
  • 7.5.3. Financial Overview
  • 7.5.4. Product Listing
  • 7.5.5. Entropy
• 7.6. Cook
  • 7.6.1. Company Overview
  • 7.6.2. Company Snapshot
  • 7.6.3. Financial Overview
  • 7.6.4. Product Listing
  • 7.6.5. Entropy
• 7.7. Biosensors International Group, Ltd.
  • 7.7.1. Company Overview
  • 7.7.2. Company Snapshot
  • 7.7.3. Financial Overview
  • 7.7.4. Product Listing
  • 7.7.5. Entropy
• 7.8. MicroPort Scientific Corporation
  • 7.8.1. Company Overview
  • 7.8.2. Company Snapshot
  • 7.8.3. Financial Overview
  • 7.8.4. Product Listing
  • 7.8.5. Entropy
• 7.9. Terumo Corporation
  • 7.9.1. Company Overview
  • 7.9.2. Company Snapshot
  • 7.9.3. Financial Overview
  • 7.9.4. Product Listing
  • 7.9.5. Entropy
• 7.10. BD
  • 7.10.1. Company Overview
  • 7.10.2. Company Snapshot
  • 7.10.3. Financial Overview
  • 7.10.4. Product Listing
  • 7.10.5. Entropy
• 7.11. Demax Medical Technology
  • 7.11.1. Company Overview
  • 7.11.2. Company Snapshot
  • 7.11.3. Financial Overview
  • 7.11.4. Product Listing
  • 7.11.5. Entropy
• 7.12. BrosMed Medical Co., Ltd.
  • 7.12.1. Company Overview
  • 7.12.2. Company Snapshot
  • 7.12.3. Financial Overview
  • 7.12.4. Product Listing
  • 7.12.5. Entropy
• 7.13. Cordis
  • 7.13.1. Company Overview
  • 7.13.2. Company Snapshot
  • 7.13.3. Financial Overview
  • 7.13.4. Product Listing
  • 7.13.5. Entropy
• 7.14. Sino Medical Sciences Technology Inc.
  • 7.14.1. Company Overview
  • 7.14.2. Company Snapshot
  • 7.14.3. Financial Overview
  • 7.14.4. Product Listing
  • 7.14.5. Entropy
• 7.15. Concept Medical
  • 7.15.1. Company Overview
  • 7.15.2. Company Snapshot
  • 7.15.3. Financial Overview
  • 7.15.4. Product Listing
  • 7.15.5. Entropy

8. KOL Views

9. Project Approach

10. DelveInsight Capabilities

11. About DelveInsight

12. Disclaimer & Contact Us